PDB Short entry for 2OJJ HEADER TRANSFERASE 12-JAN-07 2OJJ TITLE CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4- TITLE 2 FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)- TITLE 3 1H-PYRROLE-2-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK-2, MITOGEN- COMPND 5 ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2, P42-MAPK, ERT1; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PT7BLUE KEYWDS KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.XIE,M.D.JACOBS REVDAT 5 27-DEC-23 2OJJ 1 REMARK SEQADV REVDAT 4 18-OCT-17 2OJJ 1 REMARK REVDAT 3 24-FEB-09 2OJJ 1 VERSN REVDAT 2 27-MAR-07 2OJJ 1 JRNL REVDAT 1 06-FEB-07 2OJJ 0 JRNL AUTH A.M.ARONOV,C.BAKER,G.W.BEMIS,J.CAO,G.CHEN,P.J.FORD, JRNL AUTH 2 U.A.GERMANN,J.GREEN,M.R.HALE,M.JACOBS,J.W.JANETKA,F.MALTAIS, JRNL AUTH 3 G.MARTINEZ-BOTELLA,M.N.NAMCHUK,J.STRAUB,Q.TANG,X.XIE JRNL TITL FLIPPED OUT: STRUCTURE-GUIDED DESIGN OF SELECTIVE JRNL TITL 2 PYRAZOLYLPYRROLE ERK INHIBITORS. JRNL REF J.MED.CHEM. V. 50 1280 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17300186 JRNL DOI 10.1021/JM061381F REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 306843.688 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.2 REMARK 3 NUMBER OF REFLECTIONS : 13512 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 686 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2310 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2290 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 698 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 13826 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1788 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE : 0.3620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2815 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.01000 REMARK 3 B22 (A**2) : 8.89000 REMARK 3 B33 (A**2) : 0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.33 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.003 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.520 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.350 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.260 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.940 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.880 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 41.55 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : INHIB.PAR REMARK 3 PARAMETER FILE 4 : PARMXRAY.XPL REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OJJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041214. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13923 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 55.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.47 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.23400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 14 MG/ML, 20 MM TRIS, PH 7.0, REMARK 280 5 MM DTT, 200 MM NACL. PRECIPITANT: 100 MM HEPES, PH 7.2, 28-30% REMARK 280 PEG-MME-2000, 200 MM AMMONIUM SULFATE, 20 MM 2-ME, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.74400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 GLY A -20 REMARK 465 SER A -19 REMARK 465 SER A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 LEU A -8 REMARK 465 VAL A -7 REMARK 465 PRO A -6 REMARK 465 ARG A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 HIS A -2 REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 ALA A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 PRO A 9 REMARK 465 GLU A 10 REMARK 465 MET A 11 REMARK 465 VAL A 12 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 15 -138.85 -65.73 REMARK 500 ASN A 25 82.70 66.31 REMARK 500 LYS A 46 -2.45 64.26 REMARK 500 ARG A 146 -2.41 72.99 REMARK 500 ASP A 147 39.76 -146.13 REMARK 500 ASP A 165 85.66 66.30 REMARK 500 ASP A 173 68.86 -151.00 REMARK 500 LEU A 198 -60.95 -105.42 REMARK 500 ASN A 199 15.64 -159.20 REMARK 500 LEU A 292 45.87 -93.21 REMARK 500 ASP A 316 97.91 -162.71 REMARK 500 PHE A 329 150.08 -42.96 REMARK 500 ASP A 330 157.70 -43.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 82A A 360 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OJG RELATED DB: PDB REMARK 900 RELATED ID: 2OJI RELATED DB: PDB REMARK 900 RELATED ID: 2OK1 RELATED DB: PDB DBREF 2OJJ A 0 358 UNP P28482 MK01_HUMAN 1 359 SEQADV 2OJJ MET A -21 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ GLY A -20 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ SER A -19 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ SER A -18 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ HIS A -17 UNP P28482 EXPRESSION TAG SEQADV 2OJJ HIS A -16 UNP P28482 EXPRESSION TAG SEQADV 2OJJ HIS A -15 UNP P28482 EXPRESSION TAG SEQADV 2OJJ HIS A -14 UNP P28482 EXPRESSION TAG SEQADV 2OJJ HIS A -13 UNP P28482 EXPRESSION TAG SEQADV 2OJJ HIS A -12 UNP P28482 EXPRESSION TAG SEQADV 2OJJ SER A -11 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ SER A -10 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ GLY A -9 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ LEU A -8 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ VAL A -7 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ PRO A -6 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ ARG A -5 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ GLY A -4 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ SER A -3 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ HIS A -2 UNP P28482 CLONING ARTIFACT SEQADV 2OJJ MET A -1 UNP P28482 CLONING ARTIFACT SEQRES 1 A 380 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 380 LEU VAL PRO ARG GLY SER HIS MET ALA ALA ALA ALA ALA SEQRES 3 A 380 ALA GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE SEQRES 4 A 380 ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY SEQRES 5 A 380 GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN SEQRES 6 A 380 VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO SEQRES 7 A 380 PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU SEQRES 8 A 380 ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE SEQRES 9 A 380 GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN SEQRES 10 A 380 MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR SEQRES 11 A 380 ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN SEQRES 12 A 380 ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY SEQRES 13 A 380 LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP SEQRES 14 A 380 LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP SEQRES 15 A 380 LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP SEQRES 16 A 380 PRO ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL SEQRES 17 A 380 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 18 A 380 SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL SEQRES 19 A 380 GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE SEQRES 20 A 380 PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE SEQRES 21 A 380 LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN SEQRES 22 A 380 CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER SEQRES 23 A 380 LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE SEQRES 24 A 380 PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS SEQRES 25 A 380 MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU SEQRES 26 A 380 GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP SEQRES 27 A 380 PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE SEQRES 28 A 380 ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS SEQRES 29 A 380 GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY SEQRES 30 A 380 TYR ARG SER HET SO4 A 359 5 HET 82A A 360 31 HETNAM SO4 SULFATE ION HETNAM 82A (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4- HETNAM 2 82A (4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2- HETNAM 3 82A CARBOXAMIDE FORMUL 2 SO4 O4 S 2- FORMUL 3 82A C22 H17 CL2 F N4 O2 FORMUL 4 HOH *59(H2 O) HELIX 1 1 HIS A 59 LEU A 74 1 16 HELIX 2 2 LEU A 110 GLN A 117 1 8 HELIX 3 3 SER A 120 ALA A 141 1 22 HELIX 4 4 LYS A 149 SER A 151 5 3 HELIX 5 5 ASP A 173 ASP A 177 5 5 HELIX 6 6 THR A 188 ARG A 192 5 5 HELIX 7 7 ALA A 193 ASN A 199 1 7 HELIX 8 8 LYS A 205 ASN A 222 1 18 HELIX 9 9 HIS A 230 GLY A 243 1 14 HELIX 10 10 SER A 246 CYS A 252 1 7 HELIX 11 11 ASN A 255 SER A 264 1 10 HELIX 12 12 PRO A 272 PHE A 277 1 6 HELIX 13 13 ASP A 281 LEU A 292 1 12 HELIX 14 14 GLU A 301 ALA A 307 1 7 HELIX 15 15 HIS A 308 GLU A 312 5 5 HELIX 16 16 ASP A 316 GLU A 320 5 5 HELIX 17 17 PRO A 337 ALA A 350 1 14 HELIX 18 18 ARG A 351 GLN A 353 5 3 SHEET 1 A 5 TYR A 23 GLU A 31 0 SHEET 2 A 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 A 5 ARG A 48 ILE A 54 -1 O ILE A 51 N CYS A 38 SHEET 4 A 5 VAL A 99 GLN A 103 -1 O GLN A 103 N ALA A 50 SHEET 5 A 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 B 3 THR A 108 ASP A 109 0 SHEET 2 B 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 B 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 C 2 VAL A 143 LEU A 144 0 SHEET 2 C 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 SITE 1 AC1 3 ARG A 189 ARG A 192 TYR A 231 SITE 1 AC2 17 ILE A 29 GLY A 30 GLU A 31 GLY A 32 SITE 2 AC2 17 GLY A 35 VAL A 37 ALA A 50 LYS A 52 SITE 3 AC2 17 ILE A 82 GLN A 103 ASP A 104 MET A 106 SITE 4 AC2 17 ASP A 109 ASN A 152 LEU A 154 ASP A 165 SITE 5 AC2 17 HOH A 369 CRYST1 48.612 69.488 60.053 90.00 109.86 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020571 0.000000 0.007430 0.00000 SCALE2 0.000000 0.014391 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017705 0.00000